Search for: "In Re Silicone Gel Prod. Liability Litigation"
Results 1 - 12
of 12
Sorted by Relevance
|
Sort by Date
8 Apr 2019, 9:35 am
Back in 2001, in the aftermath of the silicone gel breast implant litigation, I participated in a Federal Judicial Center (FJC) television production of “Science in the Courtroom, program 6” (2001). [read post]
2 May 2019, 10:44 am
Tex. 2005). [4] In re Bextra & Celebrex Marketing Sales Practices & Prod. [read post]
26 May 2020, 6:22 am
” The late Judge Sam Pointer, appointed to preside over MDL 926, In re Silicone Gel Breast Implants Products Liability Litigation, Master File No. [read post]
19 Mar 2022, 2:09 pm
The important divide between regulatory practice and the litigation of causal claims in civil actions arises from the theoretical nature of the risk assessment enterprise. [read post]
14 Nov 2020, 10:11 am
See also In re Zofran (Ondansetron) Prod. [read post]
14 Nov 2020, 10:11 am
See also In re Zofran (Ondansetron) Prod. [read post]
18 Apr 2012, 4:40 pm
They point to litigations, such as the Bendectin and silicone gel breast implant cases, where the defense challenges were supported in part by a body of “exonerative” epidemiologic studies. [read post]
9 Apr 2016, 8:58 am
In re Zoloft Prod. [read post]
12 Jun 2023, 1:09 pm
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]
14 Aug 2011, 9:11 am
In the silicone gel breast implant litigation, for instance, plaintiffs relied upon a collection of studies that looked very plausible from their peer-reviewed publications. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
18 Mar 2011, 10:04 am
August 16, 2001) (excluding causation opinion testimony given contrary epidemiologic studies; noting that sufficient epidemiologic evidence requires relative risk greater than two) In re Silicone Gel Breast Implant Litig., 318 F. [read post]
